NZ endometriosis research to influence local policy-making
Photo:
Supplied
Researchers hope to get a clearer idea of how endometriosis affects New Zealand sufferers, with the launch of a major new project.
Until next March, Endometriosis New Zealand and the University of Canterbury will run monthly surveys for women over the age of 18, who have suspected or confirmed endometriosis.
Endometriosis is an often painful and debilitating condition in which tissue similar to the inner lining of the uterus grows outside the uterus.
Endometriosis New Zealand chief executive Tanya Cooke said it was a "landmark study" for sufferers.
"For too long, their experiences have been under-recognised in health and policy settings," she said. "This research will provide the information we need to push for meaningful change and inform the development of a future National Endometriosis Action Plan."
Lead researcher and PhD candidate Katherine Ellis said about 120,000 women were affected here, but little is known about it.
She hoped the study would have a significant impact on policy-making and medical practices for sufferers in Aotearoa.
"We know endometriosis has wide-ranging impacts on people's lives, from chronic pain and fertility issues to lost income and disrupted education.
"Currently, we have to rely mainly on international data to try to understand these issues. This research will provide us with New Zealand-specific data to inform health system responses, influence government policy and help target support.
"This project is about turning the lived experiences of those with endometriosis into insights that can contribute towards better policymaking in future."
The 10 monthly surveys each take about 10 minutes to complete.
Participants can sign up via the
Endometriosis New Zealand website
, she added.
Sign up for Ngā Pitopito Kōrero
,
a daily newsletter curated by our editors and delivered straight to your inbox every weekday.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
RNZ News
6 hours ago
- RNZ News
From whale vomit to Victorian mourning jewellery:
Topics: history, arts, books Ranging from whale vomit to Victorian mourning jewellery, Una Cruickshank's often astonishing book of essays The Chthonic Cycle meditates on the wonders of the earth and our use and abuse of them. In a time of calls of 'ecological crisis' - when many are trying to gain perspective on what they can and can't do - Una's is a fresh storytelling take on the Victorian cabinet of curiosities. Or, as the Germans aptly called it, a wunderkamma - a room of wonder. Objects and substances to hand, like pearls, coral, jet, amber, electricity and oil, lead to often funny and fascinating tales around their value and journey over epochs. Spiralling in and out of time, Cruickshank is governed by a cycle in which everything comes from, and ultimately returns to, the earth. Tamaki Makaurau raised and now Poneke based, Una Cruickshank is a graduate of the International Institute of Modern Letters and now works as an archivist at national archive Nga Taonga Sound and Vision. The Chthonic Cycle published by Te Herenga Waka University Press won a prize in the Best First Book category of this year's Ockham New Zealand Book Awards. And Una was also recently named in competition The New Voices of Aotearoa as one of "the country's ten best upcoming authors to read and follow" . Link: emails for thank you: To embed this content on your own webpage, cut and paste the following: See terms of use.
RNZ News
8 hours ago
- RNZ News
Security regulator warns against hospital security guards doubling as cleaners
By Jeremy Wilkinson, Open Justice multimedia journalist of Concerns have been raised about hospital security guards doubling as cleaners. Photo: 123RF Security guards at two rural hospitals are doubling as cleaners, leading to concerns about the safety of patients and hospital staff. The integrated model meant ISS Facility Services Limited's employees contracted to do security work at Health New Zealand-operated hospitals in Te Kūiti and Tokoroa could also pick up cleaning and orderlies duties on the same shift. The model was highlighted in a recent Private Security Personnel Licensing Authority (PSPLA) decision in which the head of the authority, Trish McConnell, raised concerns about the dual workload. "...where a security threat arises, the sooner appropriately trained security guards respond, the more likely it is for the situation to be resolved without serious harm," McConnell wrote. "If the security guard is working in another part of the hospital as a cleaner or orderly when a security risk arises, there are likely to be delays in them being able to respond and remove the person or deescalate the incident. "This has the potential of putting staff and other members of the public at greater risk of harm." McConnell's concerns were prompted by a report by Department of Internal Affairs' Complaints Investigation and Prosecution Unit (CIPU) which received an unrelated complaint about ISS and its security licenses. The basis of the licensing complaint was later found to be a misunderstanding by the company and a penalty was not issued. CIPU diverged from the complaint in its report and addressed the dual working model. It said that it wasn't illegal but a legislative change should be made. Echoing CIPU's concerns, McConnell said in her decision that the model reduced the effectiveness of security guards and "has potential health and safety risks". "The integrated model used in ISS's contract with Health New Zealand fails to recognise the key preventative role security guards play in hospital security by merely being present in waiting areas, emergency departments and other areas where pressure can be high," she said. "Just having a security guard visibly on duty can significantly reduce security situations arising and volatile situations escalating." The dual model was a practice the New Zealand Nurses Organisation (NZNO) also described as being a risk to patients and hospital staff. "Every nurse has the right to go home safe from work, and patients shouldn't be injured in hospitals," NZNO health and safety spokesperson John Crocker told NZME. "Healthcare workers suffer disproportionate violence at work, and Te Whatu Ora has moral and legal obligations to keep them safe." Crocker said in some rural towns, police staffing was often limited, so hospitals relied on the protection of security guards while on shift. McConnell said the PSPLA did not have the jurisdiction to limit the scope of someone's contract. But she suggested HNZ considered her comments in its contracting arrangements. Stephanie Doe, HNZ director of operations for hospital and specialist services in the Waikato, said while the integrated model was still in place at the hospitals, opportunities were being explored to adjust it, particularly around the overnight shifts. "We will actively engage with our teams and unions to support people to feel safe at work, with a view to implementing changes over the next month." Doe said security staff at Tokoroa and Te Kūiti hospitals were on site around the clock and were in the vicinity of the emergency department and ward at night. -This story originally appeared in the New Zealand Herald .
RNZ News
9 hours ago
- RNZ News
Ozempic and Wegovy: The pros and cons, explained
A man holds a syringe with the drug Ozempic for the treatment of type 2 diabetes. Photo: ROBERTO PFEIL / AFP Earlier this week semaglutide drugs Ozempic and Wegovy were made available for prescription in New Zealand . Semaglutide originally arrived on the market in the US in 2017 as a diabetes medication, but has quickly been tied to extreme weight loss . Wegovy can be prescribed to people over the age of 12, but many of the 65 percent of New Zealanders who are overweight or obese will have trouble affording it, with an estimated price of $500 a month. The drugs have transformed our ability to manage obesity and type 2 diabetes, and have shown potential for a wide range of conditions such as Alzheimer's, addiction and depression. But there are clouds to go along with the silver linings - such as potential vision loss. "This condition, it occurs when there's insufficient blood flow to the nerves connecting the eye to the brain, and this leads to damage," US-based health reporter for New Scientist , Grace Wade, told RNZ's Sunday Morning . The specific condition was non-arteritic anterior ischemic optic neuropathy. "That can cause this sudden and permanent vision loss, usually in just one eye. Now, I should be clear this isn't total vision loss, at least usually - it's more like cloudiness, stuff like that." People using semaglutides to treat diabetes were 4.3 times more likely to develop this condition, and those using it for weight loss 7.6 times, as people using other types of diabetes medications, a 2024 study found (Wade wrote about it in New Scientist here ). The drugs work by suppressing appetite, which typically leads to weight loss as people consume fewer calories. But the weight lost was not always beneficial, Wade said. "It leads the body to break down fat, muscle and actually even bone for nutrients, and that's why… some research has found that upwards of 40 percent of the weight loss seen with these medications is due to loss of muscle mass… that makes it really important that people prioritise exercise when taking these drugs because if you don't use your muscle, you're more likely to lose it." Getting into the exercise habit was also important since one day, most people on Ozempic or Wegovy will stop taking it - putting themselves at risk of putting the weight back on if they were not regularly moving. Then there is 'Ozempic face'. "I don't think this is a clinical term yet, but it's something that's popped up a lot in social media," Wade said. "People who are taking these medications start developing... a sunken or hollowed out appearance, which can exacerbate fine lines and wrinkles, make their skin look a little more saggy. "It isn't clear exactly how common this is… but it probably has to do with just weight loss, right? If you're losing weight, as much as some people would want to target their weight loss to certain areas of their body, we can't really do that. So, you know, any sort of overall weight loss is also gonna cause a loss of fat in your face." There were also side effects for some, including constantly needing to go to the toilet, feeling bloated, belching, constipation, heartburn, fever, upset stomach - the list, collected here by the Mayo Clinic, goes on . And nearly half of people who try it make it through a three-month course, one study found. Wade also mentioned a lot of people taking semaglutide for diabetes or Alzheimer's prevention might be older and "frail", so not able to lose weight. "Drug developers are actually working to develop new drugs that have similar effects as these weight loss medications, but without the weight loss." One unexpected benefit of semaglutide was its apparent effect on not just calorie consumption, but use of addictive substances, such as alcohol and nicotine. "We aren't exactly sure why that is, but it appears to be with how these medications affect brain activity. "So these drugs curb cravings for alcohol similar to how they curb cravings for food, right? And that probably has to do with their impact on brain regions involved in reward processing and craving… "A study of more than half-a-million people with a history of opioid use disorders showed that those who took Ozempic or similar [medications] had significantly lower rates of opioid overdose than those who didn't. Grace Wade. Photo: New Scientist "Other studies have shown similar effects in people with cannabis use disorder, cigarette smokers and alcoholism." Scientists did not expect this effect, calling it an "unintended consequence". The drugs have also shown promise in reducing heart attacks and strokes, improving fertility, treating pain, improving mental health, lower the risk of kidney failure and slowing cognitive decline. "I've never encountered a group of drugs like this," Wade said. "That's what makes these drugs so remarkable, because most medications can only treat one or two conditions, right?" She said it was likely that weight loss was playing a role - as it frequently does in health - but "it doesn't seem to be the only [reason]". But there is still a lot of research to be done, she said, before we all start taking it. "Let's unravel how they can treat all of these conditions before we jump the gun and start suggesting we, you know, maybe put it in everyone's water or something." Sign up for Ngā Pitopito Kōrero, a daily newsletter curated by our editors and delivered straight to your inbox every weekday.
